Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 277

1.

A Novel Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure.

Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HC, Kim DY, Choi MS, Wang HJ, Kim IH, Yeon JE, Seo YS, Tak WY, Kim MY, Lee HJ, Kim YS, Jun DW, Sohn JH, Kwon SY, Park SH, Heo J, Jeong SH, Lee JH, Nakayama N, Mochida S, Ido A, Tsubouchi H, Takikawa H, Shalimar, Acharya SK, Bernal W, O'Grady J, Kim YJ.

Hepatology. 2018 Sep 8. doi: 10.1002/hep.30262. [Epub ahead of print]

PMID:
30194739
2.

Prevalence, predictors and impact of bacterial infection in acute on chronic liver failure patients.

Shalimar, Rout G, Jadaun SS, Ranjan G, Kedia S, Gunjan D, Nayak B, Acharya SK, Kumar A, Kapil A.

Dig Liver Dis. 2018 May 28. pii: S1590-8658(18)30757-6. doi: 10.1016/j.dld.2018.05.013. [Epub ahead of print]

PMID:
29910108
3.

Role of Indocyanine Green in Predicting Post-Transarterial Chemoembolization Liver Failure in Hepatocellular Carcinoma.

Shalimar, Jain S, Gamanagatti SR, Kedia S, Thakur B, Nayak B, Kaur H, Gunjan D, Paul SB, Acharya SK.

J Clin Exp Hepatol. 2018 Mar;8(1):28-34. doi: 10.1016/j.jceh.2017.05.012. Epub 2017 Jun 3.

PMID:
29743794
4.

Comparison of Dynamic Changes Among Various Prognostic Scores in Viral Hepatitis-Related Acute Liver Failure.

Shalimar, Sonika U, Kedia S, Mahapatra SJ, Nayak B, Yadav DP, Gunjan D, Thakur B, Kaur H, Acharya SK.

Ann Hepatol. 2018 May-June;17(3):403-412. doi: 10.5604/01.3001.0011.7384. Epub 2018 Apr 9.

5.

CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease.

Tiwari V, Kedia S, Garg SK, Rampal R, Mouli VP, Purwar A, Mitra DK, Das P, Dattagupta S, Makharia G, Acharya SK, Ahuja V.

PLoS One. 2018 Feb 28;13(2):e0193433. doi: 10.1371/journal.pone.0193433. eCollection 2018.

6.

Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection.

Gupta S, Rout G, Patel AH, Mahanta M, Kalra N, Sahu P, Sethia R, Agarwal A, Ranjan G, Kedia S, Acharya SK, Nayak B, Shalimar.

J Viral Hepat. 2018 Jul;25(7):771-778. doi: 10.1111/jvh.12870. Epub 2018 Mar 22.

PMID:
29377464
7.

Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.

Mukherjee PS, Vishnubhatla S, Amarapurkar DN, Das K, Sood A, Chawla YK, Eapen CE, Boddu P, Thomas V, Varshney S, Hidangmayum DS, Bhaumik P, Thakur B, Acharya SK, Chowdhury A.

PLoS One. 2017 Oct 26;12(10):e0187033. doi: 10.1371/journal.pone.0187033. eCollection 2017.

8.

Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145].

Puri P, Saraswat VA, Dhiman RK, Anand AC, Acharya SK, Singh SP, Chawla YK, Amarapurkar DN, Kumar A, Arora A, Dixit VK, Koshy A, Sood A, Duseja A, Kapoor D, Madan K, Srivastava A, Kumar A, Wadhawan M, Goel A, Verma A, Shalimar, Pandey G, Malik R, Agrawal S.

J Clin Exp Hepatol. 2016 Sep;6(3):263. doi: 10.1016/j.jceh.2016.09.009. Epub 2016 Oct 3.

9.

Evaluation of two-staged Fowler-Stephens laparoscopic orchidopexy (FSLO) for intra-abdominal testes (IAT).

Bagga D, Prasad A, Grover SB, Sugandhi N, Tekchandani N, Acharya SK, Samie A.

Pediatr Surg Int. 2018 Jan;34(1):97-103. doi: 10.1007/s00383-017-4170-8. Epub 2017 Oct 4.

PMID:
28980063
10.

Predictors of infection in viral-hepatitis related acute liver failure.

Shalimar, Kedia S, Sharma H, Vasudevan S, Sonika U, Upadhyaya AD, Acharya SK.

Scand J Gastroenterol. 2017 Dec;52(12):1413-1419. doi: 10.1080/00365521.2017.1374449. Epub 2017 Sep 6.

PMID:
28875762
11.

Congenital Duodenal Obstruction, Situs Inversus Totalis, and Gastric Perforation in a Neonate.

Piplani R, Acharya SK, Bagga D.

J Neonatal Surg. 2017 Apr 15;6(2):35. doi: 10.21699/jns.v5i4.463. eCollection 2017 Apr-Jun.

12.

Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome.

Shalimar, Gamanagatti SR, Patel AH, Kedia S, Nayak B, Gunjan D, Ranjan G, Paul SB, Acharya SK.

Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1174-1182. doi: 10.1097/MEG.0000000000000945.

PMID:
28763339
13.

Brownmillerite thin films as fast ion conductors for ultimate-performance resistance switching memory.

Acharya SK, Jo J, Raveendra NV, Dash U, Kim M, Baik H, Lee S, Park BH, Lee JS, Chae SC, Hwang CS, Jung CU.

Nanoscale. 2017 Jul 27;9(29):10502-10510. doi: 10.1039/c7nr04011c.

PMID:
28708191
14.

Hepatocellular Carcinoma: An Unusual Complication of Longstanding Wilson Disease.

Gunjan D, Shalimar, Nadda N, Kedia S, Nayak B, Paul SB, Gamanagatti SR, Acharya SK.

J Clin Exp Hepatol. 2017 Jun;7(2):152-154. doi: 10.1016/j.jceh.2016.09.012. Epub 2016 Sep 21.

15.

Assessment of liver fibrosis in chronic hepatitis: comparison of shear wave elastography and transient elastography.

Paul SB, Das P, Mahanta M, Sreenivas V, Kedia S, Kalra N, Kaur H, Vijayvargiya M, Ghosh S, Gamanagatti SR, Shalimar, Gupta SD, Acharya SK.

Abdom Radiol (NY). 2017 Dec;42(12):2864-2873. doi: 10.1007/s00261-017-1213-5.

PMID:
28643136
16.

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

Buti M, Gane E, Seto WK, Chan HL, Chuang WL, Stepanova T, Hui AJ, Lim YS, Mehta R, Janssen HL, Acharya SK, Flaherty JF, Massetto B, Cathcart AL, Kim K, Gaggar A, Subramanian GM, McHutchison JG, Pan CQ, Brunetto M, Izumi N, Marcellin P; GS-US-320-0108 Investigators.

Lancet Gastroenterol Hepatol. 2016 Nov;1(3):196-206. doi: 10.1016/S2468-1253(16)30107-8. Epub 2016 Sep 22. Erratum in: Lancet Gastroenterol Hepatol. 2016 Nov;1(3):e2.

PMID:
28404092
17.

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

Chan HL, Fung S, Seto WK, Chuang WL, Chen CY, Kim HJ, Hui AJ, Janssen HL, Chowdhury A, Tsang TY, Mehta R, Gane E, Flaherty JF, Massetto B, Gaggar A, Kitrinos KM, Lin L, Subramanian GM, McHutchison JG, Lim YS, Acharya SK, Agarwal K; GS-US-320-0110 Investigators.

Lancet Gastroenterol Hepatol. 2016 Nov;1(3):185-195. doi: 10.1016/S2468-1253(16)30024-3. Epub 2016 Sep 22. Erratum in: Lancet Gastroenterol Hepatol. 2016 Nov;1(3):e2.

PMID:
28404091
18.

Severity and Outcome of Acute-on-Chronic Liver Failure is Dependent on the Etiology of Acute Hepatic Insults: Analysis of 368 Patients.

Shalimar, Kedia S, Mahapatra SJ, Nayak B, Gunjan D, Thakur B, Acharya SK.

J Clin Gastroenterol. 2017 Sep;51(8):734-741. doi: 10.1097/MCG.0000000000000823.

PMID:
28296656
19.

Magnetoresistance Versus Oxygen Deficiency in Epi-stabilized SrRu1 - x Fe x O3 - δ Thin Films.

Dash U, Acharya SK, Lee BW, Jung CU.

Nanoscale Res Lett. 2017 Dec;12(1):168. doi: 10.1186/s11671-017-1950-y. Epub 2017 Mar 6.

20.

Womb, womanhood and medical ethics: concern about rising hysterectomy cases in India.

Acharya SK.

J Fam Plann Reprod Health Care. 2017 Apr;43(2):165-166. doi: 10.1136/jfprhc-2016-101649. Epub 2017 Mar 1. No abstract available.

PMID:
28249929
21.

Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients.

Shalimar, Kedia S, Gunjan D, Sonika U, Mahapatra SJ, Nayak B, Kaur H, Acharya SK.

Dig Dis Sci. 2017 Apr;62(4):1058-1066. doi: 10.1007/s10620-017-4461-x. Epub 2017 Jan 27.

PMID:
28130708
22.

Mesenteric Cyst in Association with Type-II Jejunoileal Atresia.

Piplani R, Acharya SK, Sugandhi N, Bagga D.

J Neonatal Surg. 2017 Jan 1;6(1):17. doi: 10.21699/jns.v5i4.462. eCollection 2017 Jan-Mar.

23.

Sofosbuvir plus ribavirin in treatment-naïve patients with chronic hepatitis C virus genotype 1 or 3 infection in India.

Shah SR, Chowdhury A, Mehta R, Kapoor D, Duseja A, Koshy A, Shukla A, Sood A, Madan K, Sud R, Nijhawan S, Pawan R, Prasad M, Kersey K, Jiang D, Svarovskaia E, Doehle B, Kanwar B, Subramanian M, Acharya SK, Sarin S.

J Viral Hepat. 2017 May;24(5):371-379. doi: 10.1111/jvh.12654. Epub 2016 Dec 9.

PMID:
27933698
24.

Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience.

Shalimar, Saraswat V, Singh SP, Duseja A, Shukla A, Eapen CE, Kumar D, Pandey G, Venkataraman J, Puri P, Narayanswami K, Dhiman RK, Thareja S, Nijhawan S, Bhatia S, Zachariah U, Sonika U, Varghese T, Acharya SK.

J Gastroenterol Hepatol. 2016 Oct;31(10):1742-1749. doi: 10.1111/jgh.13340.

PMID:
26989861
25.

Erratum to:Hepatic resection for predominantly large size hepatocellular carcinoma: Early and long-term results from a tertiary care center in India.

Panwar R, Pal S, Dash NR, Shalimar, Sahni P, Acharya SK, Pande GK, Chattopadhyay TK, Nundy S.

Indian J Gastroenterol. 2016 Sep;35(5):403-404. No abstract available.

PMID:
27678104
26.

Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography.

Paul SB, Dhamija E, Gamanagatti SR, Sreenivas V, Yadav DP, Jain S, Shalimar, Acharya SK.

Diagn Interv Imaging. 2017 Mar;98(3):253-260. doi: 10.1016/j.diii.2016.09.002. Epub 2016 Sep 28.

27.

Chronic hepatitis E - an emerging disease in an immunocompromised host.

Singh A, Seth R, Gupta A, Shalimar, Nayak B, Acharya SK, Das P.

Gastroenterol Rep (Oxf). 2016 Aug 10. pii: gow024. [Epub ahead of print]

28.

Hepatic resection for predominantly large size hepatocellular carcinoma: Early and long-term results from a tertiary care center in India.

Panwar R, Pal S, Dash NR, Shalimar, Sahni P, Acharya SK, Pande GK, Chattopadhyay TK, Nundy S.

Indian J Gastroenterol. 2016 Jul;35(4):280-6. doi: 10.1007/s12664-016-0678-4. Epub 2016 Aug 12. Erratum in: Indian J Gastroenterol. 2016 Sep;35(5):403-404.

PMID:
27515744
29.

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.

Puri P, Saraswat VA, Dhiman RK, Anand AC, Acharya SK, Singh SP, Chawla YK, Amarapurkar DN, Kumar A, Arora A, Dixit VK, Koshy A, Sood A, Duseja A, Kapoor D, Madan K, Srivastava A, Kumar A, Wadhawan M, Goel A, Verma A, Shalimar, Pandey G, Malik R, Agrawal S.

J Clin Exp Hepatol. 2016 Jun;6(2):119-45. doi: 10.1016/j.jceh.2016.07.001. Epub 2016 Jul 2. Review. Erratum in: J Clin Exp Hepatol. 2016 Sep;6(3):263.

30.

Gender Disparities in the Prevalence of Undernutrition and the Higher Risk among the Young Women of Indian Tribes.

Kshatriya GK, Acharya SK.

PLoS One. 2016 Jul 5;11(7):e0158308. doi: 10.1371/journal.pone.0158308. eCollection 2016.

31.

Editorial: short-length stenoses of hepatic venous outflow tract - an Asian specificity? Authors' reply.

Acharya SK, Shalimar, Kedia S.

Aliment Pharmacol Ther. 2016 Jul;44(2):201-2. doi: 10.1111/apt.13668. No abstract available.

32.

Demographic profile, host, disease & viral predictive factors of response in patients with chronic hepatitis C virus infection at a tertiary care hospital in north India.

Vasudevan S; Shalimar, Kavimandan A, Kalra N, Nayak B, Thakur B, Das P, Gupta SD, Panda SK, Acharya SK.

Indian J Med Res. 2016 Mar;143(3):331-40. doi: 10.4103/0971-5916.182624.

33.

Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score.

Shalimar, Kumar A, Kedia S, Sharma H, Gamanagatti SR, Gulati GS, Nayak B, Thakur B, Acharya SK.

Aliment Pharmacol Ther. 2016 Jun;43(11):1154-67. doi: 10.1111/apt.13604. Epub 2016 Apr 7.

34.

Proteome analysis of the macroscopically affected colonic mucosa of Crohn's disease and intestinal tuberculosis.

Rukmangadachar LA, Makharia GK, Mishra A, Das P, Hariprasad G, Srinivasan A, Gupta SD, Ahuja V, Acharya SK.

Sci Rep. 2016 Mar 18;6:23162. doi: 10.1038/srep23162.

35.

Epitaxial Brownmillerite Oxide Thin Films for Reliable Switching Memory.

Acharya SK, Nallagatla RV, Togibasa O, Lee BW, Liu C, Jung CU, Park BH, Park JY, Cho Y, Kim DW, Jo J, Kwon DH, Kim M, Hwang CS, Chae SC.

ACS Appl Mater Interfaces. 2016 Mar;8(12):7902-11. doi: 10.1021/acsami.6b00647. Epub 2016 Mar 18.

PMID:
26955744
36.

Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome.

Srivastava S, Shalimar, Vishnubhatla S, Prakash S, Sharma H, Thakur B, Acharya SK.

J Clin Exp Hepatol. 2015 Dec;5(4):276-85. doi: 10.1016/j.jceh.2015.08.003. Epub 2015 Sep 1.

37.

Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals.

Sankhyan A, Sharma C, Dutta D, Sharma T, Chosdol K, Wakita T, Watashi K, Awasthi A, Acharya SK, Khanna N, Tiwari A, Sinha S.

Sci Rep. 2016 Feb 18;6:21240. doi: 10.1038/srep21240.

38.

Triple Burden of Obesity, Undernutrition, and Cardiovascular Disease Risk among Indian Tribes.

Kshatriya GK, Acharya SK.

PLoS One. 2016 Jan 25;11(1):e0147934. doi: 10.1371/journal.pone.0147934. eCollection 2016.

39.

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015.

Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Sarin SK, Singh SP, Chawla YK, Aggarwal R, Amarapurkar D, Arora A, Dixit VK, Sood A, Shah S, Duseja A, Kapoor D, Shalimar, Madan K, Pande G, Nagral A, Kar P, Koshy A, Puri AS, Eapen CE, Thareja S.

J Clin Exp Hepatol. 2015 Sep;5(3):221-38. doi: 10.1016/j.jceh.2015.09.002. Epub 2015 Sep 21. Review.

40.

Acute on chronic liver failure because of acute hepatic insults: Etiologies, course, extrahepatic organ failure and predictors of mortality.

Shalimar, Kumar D, Vadiraja PK, Nayak B, Thakur B, Das P, Datta Gupta S, Panda SK, Acharya SK.

J Gastroenterol Hepatol. 2016 Apr;31(4):856-64. doi: 10.1111/jgh.13213.

PMID:
26519215
41.

Biliary complications of arterial chemoembolization of hepatocellular carcinoma.

Dhamija E, Paul SB, Gamanagatti SR, Acharya SK.

Diagn Interv Imaging. 2015 Nov;96(11):1169-75. doi: 10.1016/j.diii.2015.06.017. Epub 2015 Aug 17.

42.

Management in acute liver failure.

Shalimar, Acharya SK.

J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S104-15. doi: 10.1016/j.jceh.2014.11.005. Epub 2014 Dec 3. Review.

43.

Genome-wide gene expression analysis for target genes to differentiate patients with intestinal tuberculosis and Crohn's disease and discriminative value of FOXP3 mRNA expression.

Ahuja V, Subodh S, Tuteja A, Mishra V, Garg SK, Gupta N, Makharia G, Acharya SK.

Gastroenterol Rep (Oxf). 2016 Feb;4(1):59-67. doi: 10.1093/gastro/gov015. Epub 2015 May 11.

44.

Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.

Duseja A, Singh SP, Saraswat VA, Acharya SK, Chawla YK, Chowdhury S, Dhiman RK, Jayakumar RV, Madan K, Misra SP, Mishra H, Modi SK, Muruganathan A, Saboo B, Sahay R, Upadhyay R.

J Clin Exp Hepatol. 2015 Mar;5(1):51-68. doi: 10.1016/j.jceh.2015.02.006. Epub 2015 Mar 6. Review.

45.

Editorial: hepatocellular carcinoma--a rare complication of hepatic venous outflow tract obstruction---authors' reply.

Acharya SK, Paul SB.

Aliment Pharmacol Ther. 2015 Jun;41(11):1213-4. doi: 10.1111/apt.13209. No abstract available.

46.

Transanal impalement of double J steel bar with colonic and jejunal injury: A unique pediatric case report.

Gupta D, Yadav DK, Panda SS, Panda M, Bagga D, Acharya SK, Anand N, Naredi BK.

J Nat Sci Biol Med. 2015 Jan-Jun;6(1):217-9. doi: 10.4103/0976-9668.149186.

47.

Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction.

Paul SB, Shalimar, Sreenivas V, Gamanagatti SR, Sharma H, Dhamija E, Acharya SK.

Aliment Pharmacol Ther. 2015 May;41(10):961-71. doi: 10.1111/apt.13173. Epub 2015 Mar 23.

48.

The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.

Kumar A, Acharya SK, Singh SP, Saraswat VA, Arora A, Duseja A, Goenka MK, Jain D, Kar P, Kumar M, Kumaran V, Mohandas KM, Panda D, Paul SB, Ramachandran J, Ramesh H, Rao PN, Shah SR, Sharma H, Thandassery RB; (The INASL Task-Force on Hepatocellular Carcinoma).

J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S3-S26. doi: 10.1016/j.jceh.2014.04.003. Epub 2014 May 22. Review.

49.

Epidemiology of hepatocellular carcinoma in India.

Acharya SK.

J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S27-33. doi: 10.1016/j.jceh.2014.05.013. Epub 2014 Jun 20. Review.

50.

Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver.

Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, Agarwal S, Duseja A, Puri P, Kalra N, Rameshbabu CS, Bhatia V, Sharma M, Kumar M, Gupta S, Taneja S, Kaman L, Zargar SA, Nundy S, Singh SP, Acharya SK, Dilawari JB.

J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S2-S14. doi: 10.1016/j.jceh.2014.02.003. Epub 2014 Feb 25. Review.

Supplemental Content

Loading ...
Support Center